CompanyGraph
Beijing Chunlizhengda Medical Instruments Co., Ltd.
688236 · SSE · China
clzd.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleLevered free cash flow is $49.38M, above the global median of $16.24M
- PositionDebt-to-equity is 0×, lower than 95% of its Medical Devices peers (median 0.11×)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.07%
Annual Rate
CNY 0.30Paid semi-annual
Payout Ratio
6.9%Sustainable
Payback Period
40.2 yr
Last Ex-Dividend
Jul 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.55BCNY825.25M · vs all stocks (USD)
Trailing P/E
20.28xvs Medical Devices peers
Revenue (TTM)
1.03BCNY153.60M · vs all stocks (USD)
Profit Margin
26.74%vs Medical Devices peers
Beta
-0.2360xvs all stocks
52-Week Change
-36.08%vs all stocks
Forward Annual Dividend Yield
2.07%vs all stocks
Market Capitalization
5.55BCNY825.25M · vs all stocks (USD)
Enterprise Value
3.53BCNY525.10M · vs all stocks (USD)
Trailing P/E
20.28xvs Medical Devices peers
Forward P/E
16.18xvs Medical Devices peers
Price to Sales (TTM)
5.33xvs Medical Devices peers
Price to Book (MRQ)
1.81xvs Medical Devices peers
Enterprise to Revenue
3.42xvs Medical Devices peers
Enterprise to EBITDA
11.03xvs Medical Devices peers
Profit Margin
26.74%vs Medical Devices peers
Operating Margin
30.58%vs Medical Devices peers
Return on Assets (TTM)
4.93%vs Medical Devices peers
Return on Equity (TTM)
9.32%vs Medical Devices peers
Revenue (TTM)
1.03BCNY153.60M · vs all stocks (USD)
Revenue per Share (TTM)
2.69CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-5.60%vs Medical Devices peers
Gross Profit (TTM)
643.90MCNY95.75M · vs all stocks (USD)
EBITDA (TTM)
350.54MCNY52.13M · vs all stocks (USD)
Net Income (TTM)
276.18MCNY41.07M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
6.30%vs Medical Devices peers
Operating Cash Flow (TTM)
469.26MCNY69.78M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
332.06MCNY49.38M · vs all stocks (USD)
Forward Annual Dividend Rate
0.3000CNYUpdated Aug 21, 2026Forward Annual Dividend Yield
2.07%vs all stocks
Trailing Annual Dividend Rate
0.3600CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
2.48%vs all stocks
Payout Ratio
6.90%vs Medical Devices peers
Minority Interest (Equity)
1.52MCNYFY2025 · Dec 31, 2025Revenue
1.05BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
355.13MCNYFY2025 · Dec 31, 2025Gross Profit
690.64MCNYFY2025 · Dec 31, 2025Operating Income
322.73MCNY47.99M · vs all stocks (USD)
Pre-tax Income
301.71MCNYFY2025 · Dec 31, 2025Income Tax Expense
29.09MCNYFY2025 · Dec 31, 2025Net Income
272.63MCNYFY2025 · Dec 31, 2025EBIT
301.75MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
350.54MCNYFY2025 · Dec 31, 2025Research & Development
118.50MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
137.91MCNYFY2025 · Dec 31, 2025Other Operating Expenses
8.25MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
15.28MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
39.15KCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-82.77KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.40BCNYFY2025 · Dec 31, 2025Capital Expenditures
-59.10MCNYFY2025 · Dec 31, 2025Net Acquisitions
-2.20MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.75BCNYFY2025 · Dec 31, 2025Sale of Investments
1.70BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-111.70MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-18.73MCNYFY2025 · Dec 31, 2025Other Financing Charges
-10.79MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-29.51MCNYFY2025 · Dec 31, 2025Shares Outstanding
382.19MSharesUpdated Aug 21, 2026Float Shares
157.76MSharesUpdated Aug 21, 2026% Held by Insiders
76.10%vs all stocks
% Held by Institutions
11.26%vs all stocks
Total Cash (MRQ)
2.11BCNY313.79M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.52CNYUpdated Aug 21, 2026Total Debt (MRQ)
2.24MCNY333.29K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0007xvs Medical Devices peers
Current Ratio (MRQ)
6.09xvs Medical Devices peers
Book Value per Share (MRQ)
7.97CNYUpdated Aug 21, 2026Total Assets
3.66BCNY544.45M · vs all stocks (USD)
Total Current Assets
3.01BCNYFY2025 · Dec 31, 2025Total Liabilities
674.14MCNYFY2025 · Dec 31, 2025Total Non-current Assets
649.63MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
95.54MCNYFY2025 · Dec 31, 2025Total Current Liabilities
578.60MCNYFY2025 · Dec 31, 2025Cash
1.41BCNYFY2025 · Dec 31, 2025Cash Equivalents
687.76KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.41BCNYFY2025 · Dec 31, 2025Other Short-term Investments
811.25MCNYFY2025 · Dec 31, 2025Accounts Receivable
225.46MCNYFY2025 · Dec 31, 2025Inventory
535.93MCNYFY2025 · Dec 31, 2025Accounts Payable
160.77MCNYFY2025 · Dec 31, 2025Short-term Debt
2.68MCNYFY2025 · Dec 31, 2025Other Current Liabilities
500.00KCNYFY2025 · Dec 31, 2025Long-term Debt
598.05KCNYFY2025 · Dec 31, 2025Common Stock (Book)
383.57MCNYFY2025 · Dec 31, 2025Retained Earnings
1.35BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.99BCNY444.20M · vs all stocks (USD)
Treasury Stock
20.01MCNYFY2025 · Dec 31, 202552-Week Low
13.11CNYUpdated Aug 21, 202652-Week High
29.67CNYUpdated Aug 21, 202652-Week Change
-36.08%vs all stocks
Beta
-0.2360xvs all stocks
50-Day MA
14.77CNYUpdated Aug 21, 2026200-Day MA
20.02CNYUpdated Aug 21, 2026Avg 10-Day Volume
2.17MSharesUpdated Aug 21, 2026Avg 30-Day Volume
2.57MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.7100CNYUpdated Aug 21, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 0×, lower than 95% of its Medical Devices peers (median 0.11×)Notable
Debt-to-equity: 0.00Industry median: 0.11Industry P5: 0.00Peers compared: 102
Financial Health
Altman Z-Score 6.81: safe zoneNotable
Altman Z-Score: 6.81
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Levered free cash flow is $49.38M, above the global median of $16.24MNotable
Levered free cash flow (USD): 49,380,537.908Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
HK inno.N Corporation
Tier 1ProductionApproval-Gated PipelineRule
Gansu Longshenrongfa Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Esperion Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Bioventus Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shouyao Holdings Beijing Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chengda Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Konruns Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shenzhen YHLO Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pharming Group N.V.
Tier 1ProductionApproval-Gated PipelineRule
R&G Pharmastudies Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Wuxi Honghui New Materials Co., Ltd.
2 interpretationsPrice Below Mean With Profitability And EquityHigh Retained Earnings With Profitability And Equity
Sijin Intelligent Forming Co., Ltd.
2 interpretationsPrice Below Mean With Profitability And EquityHigh Retained Earnings With Profitability And Equity
Sf Oilless Bearing Co. Ltd.
2 interpretationsPrice Below Mean With Profitability And EquityHigh Retained Earnings With Profitability And Equity